Stephen K Tyring, MD, PhD, FAAD
SESSIONS
DISCLOSURES
AbbVie – Investigator(Grants/Research Funding), Speaker(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Genocea Biosciences – Investigator(Grants/Research Funding); GlaxoSmithKline – Speaker(Honoraria); Glenmark Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); IQVIA – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Menlo Therapeutics Inc. – Investigator(Grants/Research Funding); Merck & Co., Inc – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Nycomed Amersham – Investigator(Grants/Research Funding); Parexel – Investigator(Grants/Research Funding); Quintiles Pharma – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Trevi Therapeutics – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Vical Incorporated – Investigator(Grants/Research Funding);